Belite Bio initiated at Buy by Canaccord Genuity
Canaccord Genuity initiated coverage on Belite Bio with a Buy rating and set a $303.00 per-share price target.
Ratings actions GMT) Belite Bio Price Target Announced at $303.00/Share by Canaccord GenuityRatings actions